TY - JOUR
T1 - A review of a strategic roadmapping exercise to advance clinical translation of photoacoustic imaging: From current barriers to future adoption
AU - Assi, Hisham
AU - Cao, Rui
AU - Castelino, Madhura
AU - Cox, Ben
AU - Gilbert, Fiona j.
AU - Gröhl, Janek
AU - Gurusamy, Kurinchi
AU - Hacker, Lina
AU - Ivory, Aoife m.
AU - Joseph, James
AU - Knieling, Ferdinand
AU - Leahy, Martin j.
AU - Lilaj, Ledia
AU - Manohar, Srirang
AU - Meglinski, Igor
AU - Moran, Carmel
AU - Murray, Andrea
AU - Oraevsky, Alexander a.
AU - Pagel, Mark d.
AU - Pramanik, Manojit
AU - Raymond, Jason
AU - Singh, Mithun kuniyil ajith
AU - Vogt, William c.
AU - Wang, Lihong
AU - Yang, Shufan
AU - Members of ipasc, null
AU - Bohndiek, Sarah e.
N1 - Funding: This work was funded by UKRI grant EP/V027069/1
Copyright © 2023 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
PY - 2023/8
Y1 - 2023/8
N2 - Photoacoustic imaging (PAI), also referred to as optoacoustic imaging, has shown promise in early-stage clinical trials in a range of applications from inflammatory diseases to cancer. While the first PAI systems have recently received regulatory approvals, successful adoption of PAI technology into healthcare systems for clinical decision making must still overcome a range of barriers, from education and training to data acquisition and interpretation. The International Photoacoustic Standardisation Consortium (IPASC) undertook an community exercise in 2022 to identify and understand these barriers, then develop a roadmap of strategic plans to address them. Here, we outline the nature and scope of the barriers that were identified, along with short-, medium- and longterm community efforts required to overcome them, both within and beyond the IPASC group.
AB - Photoacoustic imaging (PAI), also referred to as optoacoustic imaging, has shown promise in early-stage clinical trials in a range of applications from inflammatory diseases to cancer. While the first PAI systems have recently received regulatory approvals, successful adoption of PAI technology into healthcare systems for clinical decision making must still overcome a range of barriers, from education and training to data acquisition and interpretation. The International Photoacoustic Standardisation Consortium (IPASC) undertook an community exercise in 2022 to identify and understand these barriers, then develop a roadmap of strategic plans to address them. Here, we outline the nature and scope of the barriers that were identified, along with short-, medium- and longterm community efforts required to overcome them, both within and beyond the IPASC group.
KW - photoacoustic imaging
KW - optoacoustic tomography
KW - standardisation
KW - quality assurance
KW - phantoms
KW - clinical translation
UR - https://www.sciencedirect.com/science/article/pii/S2213597923000927
U2 - 10.1016/j.pacs.2023.100539
DO - 10.1016/j.pacs.2023.100539
M3 - Article
C2 - 37600964
SN - 2213-5979
VL - 32
SP - 100539
JO - Photoacoustics
JF - Photoacoustics
M1 - 100539
ER -